Xiaosong Li

647 total citations
18 papers, 469 citations indexed

About

Xiaosong Li is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Immunology. According to data from OpenAlex, Xiaosong Li has authored 18 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Biomedical Engineering and 6 papers in Immunology. Recurrent topics in Xiaosong Li's work include Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (6 papers) and Photodynamic Therapy Research Studies (5 papers). Xiaosong Li is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (6 papers) and Photodynamic Therapy Research Studies (5 papers). Xiaosong Li collaborates with scholars based in China, United States and Bahamas. Xiaosong Li's co-authors include Wei R. Chen, Robert E. Nordquist, Wenyang Jiang, Yuyan Xiong, Yuejin Yang, Yan Fu, Henry H. Le, Mark F. Naylor, Cynthia K. Murray and T. Kent Teague and has published in prestigious journals such as Medicine, IEEE Journal of Selected Topics in Quantum Electronics and Nanomedicine Nanotechnology Biology and Medicine.

In The Last Decade

Xiaosong Li

17 papers receiving 465 citations

Peers

Countries citing papers authored by Xiaosong Li

Since Specialization

Citations

This map shows the geographic impact of Xiaosong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaosong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaosong Li more than expected).

Fields of papers citing papers by Xiaosong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaosong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaosong Li. The network helps show where Xiaosong Li may publish in the future.

Co-authorship network of co-authors of Xiaosong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaosong Li. A scholar is included among the top collaborators of Xiaosong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaosong Li. Xiaosong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers 2023 ·Technology in Cancer Research & Treatment ·Yingshu Cui, Yuanyuan Xu, Yi Li, Yuanyuan Sun, Jia Hu, Jia Jia, Xiaosong Li	9
2	Anti-PD1 antibody and not anti-LAG-3 antibody improves the antitumor effect of photodynamic therapy for treating metastatic breast cancer 2023 ·Journal of Innovative Optical Health Sciences ·(unknown), Yibing Zhao, Yuanyuan Xu, Bo Wang, Haixia Qiu, Hongyou Zhao, Jing Zeng, (unknown), Hui Li, (unknown), Xiaosong Li, (unknown)	0
3	Synergistic therapeutic strategies for cancer treatment based on nanophototherapy 2021 ·Nanophotonics ·Shanshan Liu, Ruixiang Song, Xiaosong Li, Feifan Zhou	9
4	Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles 2021 ·Frontiers in Cardiovascular Medicine ·Wenyang Jiang, Yuyan Xiong, Xiaosong Li, Yuejin Yang	75
5	Research Progress of Autofluorescence Imaging Technology in the Diagnosis of Early Gastrointestinal Tumors 2021 ·Cancer Control ·Yiliang Bi, Min Min, (unknown), Yuanyuan Xu, Xiaosong Li	9
6	Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report 2020 ·Therapeutic Advances in Respiratory Disease ·Jia Hu, (unknown), (unknown), Yan Fu, Dianjun Chen, Donghui Li, Nan Du, Analyn Lizaso, (unknown), Lu Zhang, Xiaosong Li	15
7	Mathematical simulation of temperature distribution in tumor tissue and surrounding healthy tissue treated by laser combined with indocyanine green 2019 ·Theoretical Biology and Medical Modelling ·Yuanyuan Xu, (unknown), (unknown), Feifan Zhou, Ning Dong, (unknown), Bo Wang, Yachao Zeng, Nan Du, Xiaosong Li, Wei R. Chen	27
8	Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer 2019 ·Nanomedicine Nanotechnology Biology and Medicine ·Yong Li, Xiaosong Li, Austin Doughty, (unknown), Lu Wang, Feifan Zhou, Robert E. Nordquist, Wei R. Chen	59
9	The Characteristics of Blue Laser Imaging and the Application in Diagnosis of Early Digestive Tract Cancer 2019 ·Technology in Cancer Research & Treatment ·Yiliang Bi, Min Min, Fengmei Zhang, Xiaosong Li	8
10	A new palliative treatment for blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature 2019 ·Journal of International Medical Research ·(unknown), Yuanyuan Xu, (unknown), Hongwei Wang, (unknown), Xiaosong Li	2
11	Characteristics of help-seeking behavior among bipolar disorder patients 2019 ·Medicine ·Dong‐Xin Wang, Jing Ma, (unknown), Yan Chen, (unknown), Huiying Wang, (unknown), Xiaosong Li, (unknown)	4
12	Photothermal therapy combined with dinitrophenyl hapten for the treatment of late stage malignant melanoma 2017 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Xiaosong Li, Nan Du, Haijun Li, (unknown), Dianjun Chen, Feifan Zhou, Yuanyuan Xu, Fuli Wang, Wei R. Chen	1
13	Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib. 2015 ·PubMed ·Yan Fu, (unknown), Hui Zhao, Jia Hu, Huanhuan Zhang, Xiaosong Li, Nan Du, Yitao Huang	34
14	Novel pH-sensitive nanoformulated docetaxel as a potential therapeutic strategy for the treatment of cholangiocarcinoma 2015 ·Journal of Nanobiotechnology ·Nan Du, (unknown), Xiaosong Li, Lei Wang, (unknown), Hongying Ma, Hui Zhao	17
15	Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion 2013 ·Oncology Reports ·Nan Du, Xiaosong Li, Fang Li, Hui Zhao, (unknown), Junxun Ma, Yan Fu, (unknown)	74
16	Laser Immunotherapy: Concept, Possible Mechanism, Clinical Applications, and Recent Experimental Results 2012 ·IEEE Journal of Selected Topics in Quantum Electronics ·Xiaosong Li, Min Min, Ying Gu, Nan Du, Tomas Hode, Robert E. Nordquist, Roman F. Wolf, Eric Howard, John Lunn, Örn Adalsteinsson, Weihua Chen	11
17	Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients 2010 ·Cancer Biology & Therapy ·Xiaosong Li, Mark F. Naylor, Henry H. Le, Robert E. Nordquist, T. Kent Teague, C. Anthony Howard, Cynthia K. Murray, Wei R. Chen	104
18	Long-Term Effect on EMT6 Tumors in Mice Induced by Combination of Laser Immunotherapy and Surgery 2010 ·Integrative Cancer Therapies ·Xiaosong Li, Henry H. Le, Roman F. Wolf, (unknown), (unknown), Robert E. Nordquist, (unknown), Hong Liu, Wei R. Chen	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact